Physician profile
Matthew Brown
NPI 1891011383
$4,083.31
in general payments reported to CMS, 2019-2025
29 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $303 · 2021: $16.60 · 2022: $1,216 · 2023: $891 · 2024: $404 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464 · Education: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.56 |
| Education | $425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $875.85 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $800.82 | 2019-2025 | Therasphere Administration Set, Varithena Administration Pack, Embold Fibered |
| Angiodynamics, INC. | $550.73 | 2019-2025 | Venacure 1470 Pro, Bioflo, Smart Port Ct |
| Stryker Corporation | $366.72 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Argon Medical Devices, INC. | $204.62 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $184.46 | 2022-2023 | Gore Viatorr Tips Endoprosthesis |
| Becton, Dickinson and Company | $144.16 | 2024-2025 | Conquest, Covera |
| Medtronic Vascular, INC. | $123.49 | 2019 | |
| Siemens Medical Solutions USA, INC. | $115.18 | 2024-2025 | Embozene, Microthermx Microwave Ablation System |
| Bard Peripheral Vascular, INC. | $102.97 | 2019 | |
| Biocompatibles, INC. | $95.03 | 2019 | |
| Terumo Medical Corporation | $60.80 | 2019-2025 | Azur Cx Detachable, Angio-Seal, Navicross |
| Ethicon US, LLC | $54.53 | 2024 | Certus 140 |
| Sirtex Medical INC | $50.35 | 2022-2023 | Sir-Spheres Microspheres |
| Delcath Systems | $46.82 | 2025 | Hepzato Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koya Medical, INC. | $36.97 | 2025 | Dayspring, Koya Medical |
| Si-Bone, INC. | $26.23 | 2025 | |
| Edwards Lifesciences Corporation | $26.21 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $26.16 | 2024 | Diamondback Peripheral |
| Trisalus Life Sciences, INC. | $24.51 | 2025 | Trinav Infusion System |
| Seqirus USA INC | $24.04 | 2025 | Flucelvax |
| Asahi Intecc USA, INC. | $23.86 | 2024-2025 | Asahi Neurology Wires, Peripheral Vascular |
| Amgen INC. | $20.16 | 2023 | Prolia, Evenity |
| Noven Therapeutics, LLC | $19.05 | 2024 | Xelstrym |
| Philips North America LLC | $18.73 | 2024 | (Br5) Peripheral Ivus |
| Lilly USA, LLC | $17.74 | 2025 | Mounjaro |
| Amarin Pharma, INC. | $16.60 | 2021 | |
| Merck Sharp & Dohme LLC | $13.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.